Aridis Pharmaceuticals, Inc.

CIK 1614067 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aridis Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003550
May 15, 2026SCHEDULE 13G/A0001172661-26-002121
Feb 17, 2026SCHEDULE 13G/A0001172661-26-001257
Aug 14, 2025SCHEDULE 13G/A0001172661-25-003618
May 15, 2025SCHEDULE 13G/A0001172661-25-002241
Feb 14, 2025SCHEDULE 13G/A0001172661-25-001220
Nov 14, 2024SC 13G/A0001172661-24-005286
Jun 28, 202440001493152-24-025678
Jun 28, 202440001493152-24-025677
Jun 28, 202440001493152-24-025670
Jun 28, 202440001493152-24-025674
Jun 28, 202440001493152-24-025672
Jun 27, 20248-K0001493152-24-025437
Feb 14, 2024SC 13G/A0001172661-24-001215
Feb 13, 2024SC 13G/A0000929638-24-000557
Jan 16, 20248-K0001493152-24-002304
Dec 18, 20238-K0001493152-23-045212
Dec 18, 2023DEFA14A0001493152-23-045213
Dec 15, 2023DEFA14A0001493152-23-045072
Nov 6, 202310-Q0001493152-23-039521
Nov 3, 2023DEF 14A0001493152-23-039191
Nov 3, 20238-K0001493152-23-039349
Nov 3, 2023DEFA14A0001493152-23-039217
Nov 3, 2023ARS0001493152-23-039196
Sep 19, 202340001493152-23-033065